Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT02522715||Recruiting||Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer||
||Other / NIH||
||39||Male||18 Years and older (Adult, Older Adult)||NCT02522715||IRB00011227
|October 13, 2015||January 31, 2019||August 31, 2025||August 13, 2015||July 30, 2018||